• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology.女性缺血性心脏病:病理生理学和危险因素方面存在性别差异吗?来自欧洲心脏病学会冠状动脉病理生理学和微循环工作组的立场文件。
Cardiovasc Res. 2011 Apr 1;90(1):9-17. doi: 10.1093/cvr/cvq394. Epub 2010 Dec 14.
2
Sex Differences in the Coronary System.冠状动脉系统的性别差异。
Adv Exp Med Biol. 2018;1065:257-278. doi: 10.1007/978-3-319-77932-4_17.
3
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.改善与缺血性心脏病和心脏保护中合并症及危险因素的性别特异性效应相关的转化研究:ESC 心脏细胞生物学工作组的立场文件和建议。
Cardiovasc Res. 2021 Jan 21;117(2):367-385. doi: 10.1093/cvr/cvaa155.
4
Sex differences in mechanisms, presentation and management of ischaemic heart disease.缺血性心脏病在发病机制、临床表现及治疗方面的性别差异。
Atherosclerosis. 2015 Jul;241(1):157-68. doi: 10.1016/j.atherosclerosis.2015.04.802. Epub 2015 Apr 27.
5
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
6
Presentation, management, and outcomes of ischaemic heart disease in women.女性缺血性心脏病的表现、治疗和结局。
Nat Rev Cardiol. 2013 Sep;10(9):508-18. doi: 10.1038/nrcardio.2013.93. Epub 2013 Jul 2.
7
Hypertension and Ischemic Heart Disease in Women.女性中的高血压与缺血性心脏病
Curr Pharm Des. 2016;22(25):3885-92. doi: 10.2174/1381612822666160414142426.
8
Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction.女性心肌缺血的其他病因:自发性冠状动脉夹层、血管痉挛性心绞痛和冠状动脉微血管功能障碍的最新进展
Vasc Med. 2017 Apr;22(2):146-160. doi: 10.1177/1358863X16686410.
9
Prospective relationship between occupational physical activity and risk of ischaemic heart disease: are men and women differently affected?职业体力活动与缺血性心脏病风险的前瞻性关系:男性和女性受影响的方式是否不同?
Eur J Prev Cardiol. 2023 Jul 12;30(9):858-867. doi: 10.1093/eurjpc/zwad067.
10
[Pathophysiology of ischemic heart disease in women].[女性缺血性心脏病的病理生理学]
G Ital Cardiol (Rome). 2012 Jun;13(6):396-400. doi: 10.1714/1073.11756.

引用本文的文献

1
Sex-Specific Patterns and Predictors of Reverse Left Ventricular Remodeling and Outcomes in STEMI Patients with LVEF ≤ 50% After Successful Primary Angioplasty.ST段抬高型心肌梗死患者成功进行直接经皮冠状动脉腔内血管成形术后左心室射血分数≤50%时,逆向左心室重构及预后的性别特异性模式和预测因素
Biomedicines. 2025 Jul 21;13(7):1782. doi: 10.3390/biomedicines13071782.
2
Lactation duration and ischemic heart disease among parous postmenopausal females from a prospective cohort study.一项前瞻性队列研究中经产绝经后女性的哺乳期时长与缺血性心脏病
Commun Med (Lond). 2025 Mar 25;5(1):86. doi: 10.1038/s43856-025-00806-w.
3
Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights.Gasdermin D介导的心肌细胞焦亡在缺血性心脏病中的治疗潜力:从实验台到临床见解的范式扩展
J Cell Mol Med. 2025 Feb;29(3):e70357. doi: 10.1111/jcmm.70357.
4
Sex-specific mechanisms in vascular aging: exploring cellular and molecular pathways in the pathogenesis of age-related cardiovascular and cerebrovascular diseases.血管衰老中的性别特异性机制:探索与年龄相关的心血管和脑血管疾病发病机制中的细胞和分子途径。
Geroscience. 2025 Feb;47(1):301-337. doi: 10.1007/s11357-024-01489-2. Epub 2025 Jan 3.
5
Bridging Care Gaps for Older Women Undergoing Percutaneous Coronary Intervention.为行经皮冠状动脉介入治疗的老年女性患者搭建护理桥梁。
Interv Cardiol Clin. 2025 Jan;14(1):69-79. doi: 10.1016/j.iccl.2024.08.006.
6
Gender differences in cardiac rehabilitation participation and outcomes: an 18-year retrospective study in Iran.心脏康复参与度及预后的性别差异:伊朗一项为期18年的回顾性研究
Egypt Heart J. 2024 Oct 4;76(1):133. doi: 10.1186/s43044-024-00565-4.
7
Skin sympathetic nerve activity and ST-segment depression in women.女性的皮肤交感神经活动与ST段压低
Heart Rhythm O2. 2024 Apr 24;5(6):396-402. doi: 10.1016/j.hroo.2024.04.009. eCollection 2024 Jun.
8
Vasodilator reactive oxygen species ameliorate perturbed myocardial oxygen delivery in exercising swine with multiple comorbidities.扩血管反应性氧物种可改善患有多种合并症的运动猪心肌氧输送紊乱。
Basic Res Cardiol. 2024 Oct;119(5):869-887. doi: 10.1007/s00395-024-01055-z. Epub 2024 May 25.
9
The Development of a Chest-Pain Protocol for Women Presenting to the Emergency Department.针对前往急诊科就诊的女性患者的胸痛诊疗方案的制定。
CJC Open. 2023 Dec 9;6(2Part B):517-529. doi: 10.1016/j.cjco.2023.12.003. eCollection 2024 Feb.
10
Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan.女性心理健康与缺血性心脏病:健康跨度内当前证据和临床考虑的综述。
Curr Atheroscler Rep. 2024 Mar;26(3):45-58. doi: 10.1007/s11883-023-01185-0. Epub 2024 Jan 19.

本文引用的文献

1
Summary health statistics for U.S. adults: National Health Interview Survey, 2008.美国成年人健康统计摘要:2008年国家健康访谈调查
Vital Health Stat 10. 2009 Dec(242):1-157.
2
Anxiety and risk of incident coronary heart disease: a meta-analysis.焦虑与冠心病事件风险:一项荟萃分析。
J Am Coll Cardiol. 2010 Jun 29;56(1):38-46. doi: 10.1016/j.jacc.2010.03.034.
3
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.腺苷介导的冠状动脉微血管反应性与疑似缺血女性患者的不良预后相关:来自美国国立心肺血液研究所 WISE(女性缺血综合征评估)研究的结果。
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32. doi: 10.1016/j.jacc.2010.01.054.
4
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management.原发性冠状动脉微血管功能障碍:临床表现、病理生理学及管理
Circulation. 2010 Jun 1;121(21):2317-25. doi: 10.1161/CIRCULATIONAHA.109.900191.
5
Gender and microvascular angina.性别与微血管性心绞痛。
J Thromb Thrombolysis. 2011 Jan;31(1):37-46. doi: 10.1007/s11239-010-0477-1.
6
Screening for cardiovascular risk in asymptomatic patients.无症状患者的心血管风险筛查。
J Am Coll Cardiol. 2010 Mar 23;55(12):1169-1177. doi: 10.1016/j.jacc.2009.09.066.
7
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.对于高敏 C 反应蛋白升高或血脂异常的女性,用他汀类药物进行心血管一级预防:来自评估瑞舒伐他汀用于预防的应用(JUPITER)的干预试验和来自一级预防试验的女性亚组的荟萃分析的结果。
Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22.
8
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.激素替代疗法治疗后的绝经后女性冠心病:风险增加会消失吗?一项随机试验。
Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005.
9
Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases.内在的微血管内皮细胞磷酸二酯酶的性别特异性差异。
Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1146-54. doi: 10.1152/ajpheart.00252.2009. Epub 2010 Feb 5.
10
Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.性激素对血管功能的实验性益处及激素疗法在心血管疾病中的疗效
Curr Cardiol Rev. 2008 Nov;4(4):309-22. doi: 10.2174/157340308786349462.

女性缺血性心脏病:病理生理学和危险因素方面存在性别差异吗?来自欧洲心脏病学会冠状动脉病理生理学和微循环工作组的立场文件。

Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology.

机构信息

Emory University Rollins School of Public Health and School of Medicine, Atlanta, GA, USA.

出版信息

Cardiovasc Res. 2011 Apr 1;90(1):9-17. doi: 10.1093/cvr/cvq394. Epub 2010 Dec 14.

DOI:10.1093/cvr/cvq394
PMID:21159671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058737/
Abstract

Cardiovascular disease (CVD) is the leading cause of death in women, and knowledge of the clinical consequences of atherosclerosis and CVD in women has grown tremendously over the past 20 years. Research efforts have increased and many reports on various aspects of ischaemic heart disease (IHD) in women have been published highlighting sex differences in pathophysiology, presentation, and treatment of IHD. Data, however, remain limited. A description of the state of the science, with recognition of the shortcomings of current data, is necessary to guide future research and move the field forward. In this report, we identify gaps in existing literature and make recommendations for future research. Women largely share similar cardiovascular risk factors for IHD with men; however, women with suspected or confirmed IHD have less coronary atherosclerosis than men, even though they are older and have more cardiovascular risk factors than men. Coronary endothelial dysfunction and microvascular disease have been proposed as important determinants in the aetiology and prognosis of IHD in women, but research is limited on whether sex differences in these mechanisms truly exist. Differences in the epidemiology of IHD between women and men remain largely unexplained, as we are still unable to explain why women are protected towards IHD until older age compared with men. Eventually, a better understanding of these processes and mechanisms may improve the prevention and the clinical management of IHD in women.

摘要

心血管疾病(CVD)是女性死亡的主要原因,在过去的 20 年中,女性动脉粥样硬化和 CVD 的临床后果的知识已经有了极大的增长。研究工作已经增加,并且已经发表了许多关于女性缺血性心脏病(IHD)各个方面的报告,强调了 IHD 的病理生理学、表现和治疗方面的性别差异。然而,数据仍然有限。描述科学现状,认识到当前数据的局限性,对于指导未来的研究和推动该领域的发展是必要的。在本报告中,我们确定了现有文献中的差距,并为未来的研究提出了建议。女性与男性患 IHD 的心血管危险因素大致相同;然而,患有疑似或确诊 IHD 的女性的冠状动脉粥样硬化程度低于男性,尽管她们年龄更大,且具有比男性更多的心血管危险因素。冠状动脉内皮功能障碍和微血管疾病已被提出作为女性 IHD 病因学和预后的重要决定因素,但关于这些机制中是否存在真正的性别差异的研究有限。女性和男性之间 IHD 的流行病学差异在很大程度上仍未得到解释,因为我们仍然无法解释为什么与男性相比,女性直到老年才对 IHD 有保护作用。最终,对这些过程和机制的更好理解可能会改善女性 IHD 的预防和临床管理。